# Evaluation of Naltrexone as a Treatment for Self-injurious Behavior

> **NCT02726035** · PHASE4 · WITHDRAWN · sponsor: **Western Michigan University School of Medicine**

## Conditions studied

- Self-injurious Behavior
- Self Mutilation

## Interventions

- **DRUG:** Naltrexone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02726035
- **Lead sponsor:** Western Michigan University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-02-22
- **Primary completion:** 2015-06-30
- **Final completion:** 2017-01-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI deceased
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02726035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02726035, "Evaluation of Naltrexone as a Treatment for Self-injurious Behavior". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02726035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*